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To the Editor: The outbreak of 
chikungunya fever that started in the 
Indian Ocean Islands in early 2005 
(1) spread through adjoining islands 
and appeared in peninsular India by 
late 2005 (2). It was ﬁ  rst noticed in 
the southern state of Andhra Pradesh 
in February 2006; it spread to Tamil 
Nadu in April 2006 and to Karnataka 
and Kerala in May. The western state 
of Gujarat also reported cases in April, 
but no cases were reported in May and 
June. The disease again reappeared 
in July and reached a peak in August. 
Later it affected the central Indian 
states of Maharashtra and Madhya 
Pradesh. In most states, the outbreak 
declined by October 2006 (3,4).
Andaman and Nicobar Islands, 
a union territory of India, is an ar-
chipelago of >500 islands and islets 
situated in the Bay of Bengal, 1,200 
km from peninsular India. People are 
constantly moving between mainland 
India and these islands. Chikungunya 
fever has previously not been reported 
from these islands.
During July and August 2006, 
medical professionals noticed an in-
crease in the number of cases of febrile 
illness in Port Blair, the headquarters 
of the union territory and the only ur-
ban area in the islands. The total num-
ber of patients with fever who visited 
the 5 urban health centers (UHC) in 
the town went up from the baseline of 
300–450 per day to 550–900 per day 
in July and August 2006. Most of the 
patients had associated joint pain. In 
view of the clinical features sugges-
tive of chikungunya fever, the ongoing 
epidemic on mainland India, and the 
widespread presence of the vector, Ae-
des aegypti, within the urban area of 
Port Blair (5), chikungunya fever was 
suspected. To conﬁ  rm this hypothesis, 
17 persons who fulﬁ  lled the case deﬁ  -
nition of having an acute febrile illness 
associated with severe pain in multiple 
joints were selected from among the 
initial patients who went to the UHCs 
and the referral hospital in Port Blair. 
Among these study participants, 15 
were adults and 2 were adolescents 
15 years of age; 6 were female and 11 
male. Four adults had febrile illness 
associated with joint pain; in these pa-
tients, weakness of all 4 limbs devel-
oped 3–15 days after onset of illness. 
All of the 4 patients with weakness 
had areﬂ  exic quadriplegia; 1 required 
ventilatory support. The patients with 
areﬂ   exic quadriplegia were treated 
with injections of methylprednisolone; 
all recovered within a week.
Blood samples were collected 
from these study participants. Serum 
samples were separated and sent to the 
National Institute of Virology, Pune, 
for detection of anti–chikungunya 
virus (CHIKV) immunoglobulin M 
(IgM) antibodies. Samples were col-
lected from 12 patients >4 days after 
the onset of symptoms. In the remain-
ing patients, the interval between onset 
of symptoms and collection of blood 
samples was <4 days. Of the 17 study 
participants, 13 were positive for anti-
CHIKV IgM antibodies. Three of 4 
samples that were negative for IgM 
antibodies to CHIKV were collected 
<3 days after the onset of symptoms. 
Among these, 2 samples were sub-
jected to reverse transcriptase–PCR 
by using the primers CHIKV/E1S (5′-
TAC CCA TTC ATG TGG GGC-3′) 
and CHIKV/E1C (5′-GCC TTT GTA 
CAC CAC GAT T-3′), as described by 
Hasebe et al. (6); both were positive 
for CHIKV RNA. All these samples 
were tested for dengue IgM antibod-
ies by using SD Bioline Dengue IgM 
Rapid Test (Standard Diagnostics Inc., 
Kyonggi-Do, South Korea), which 
uses a mixture of dengue recombinant 
envelop proteins and can detect all of 
the 4 dengue serotypes. None of the 
samples tested positive for dengue an-
tibodies. Hence, CHIKV infection was 
conﬁ  rmed in 15 of 17 patients.LETTERS
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India experienced the ﬁ  rst  con-
ﬁ  rmed outbreak of chikungunya fever 
in 1963–1964 in Kolkata (7) and in 
1965 in Chennai. The last epidemic 
in India was reported from Barsi in 
the state of Maharastra in 1973 (8). 
However, during these outbreaks, An-
daman and Nicobar Islands were not 
affected. Outbreaks of dengue fever 
and chikungunya fever are known 
to occur simultaneously, as has hap-
pened in several parts of India. How-
ever, during the current outbreak in 
Andaman Islands, dengue infection 
was not detected. (Dengue has never 
been reported in the islands.) As chi-
kungunya fever is known for its mys-
terious pattern of dramatic outbreaks 
interspersed by periods of prolonged 
absence, the introduction of this virus 
to an unexposed population has great 
public health importance. 
This outbreak could be a warning 
about preparedness for health authori-
ties not only in these islands but also 
in other areas where chikungunya fe-
ver has not occurred previously. With 
the extent of human travel to and from 
areas with active chikungunya vi-
rus transmission, many areas where 
the disease has not previously been 
reported could be at risk. As an out-
break response, the Regional Medical 
Research Centre and Directorate of 
Health Services, Andaman and Nico-
bar Administration, has undertaken a 
comprehensive community-based sur-
vey to assess the impact of chikungu-
nya fever and Aedes infestation levels. 
We are stepping up our applied ﬁ  eld 
research to prevent future outbreaks of 
chikungunya fever, as well as dengue 
fever.
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Alistipes ﬁ  negoldii 
in Blood Cultures 
from Colon Cancer 
Patients
To the Editor: Alistipes ﬁ  negol-
dii was previously isolated from ap-
pendiceal tissue samples in children 
with acute appendicitis and from 
perirectal and brain abscess material 
(1,2). 16S rDNA sequencing studies 
showed that this bacterium clustered 
with  A. putredinis (Figure) in the 
Bacteroidetes group (4). We describe 
the ﬁ  rst cases, to our knowledge, of 
bacteremia due to A. ﬁ  negoldii in 2 
patients with colon cancer who un-
derwent surgical resection.
The  ﬁ  rst patient was a 61-year-
old woman with colorectal carcinoma 
and liver metastasis, who underwent 
chemotherapy consisting of 6 cycles 
of oxaliplatin (the FOLFOX scheme, 
a chemotherapy regimen consisting of 
ﬂ  uorouracil [5 FU], folinic acid, and 
oxaliplatin). In September 2003, a left 
colectomy, resection of metastasis in 
the left side of the liver, and a ligation 
of the right portal vein were performed. 
Two months later, in a second step, a 
right hepatectomy was done. On post-
operative day 5, the patient had a fe-
ver up to 39.8°C and leukocyte count 
of 8.49 g/L (68% polymorphonuclear 
leukocytes). Two blood cultures were 
performed before antimicrobial drug 
therapy based on amoxicillin/clavu-
lanic acid and amikacin was started. 
After receiving this therapy, the pa-
tient recovered rapidly. One of the 2 
anaerobic blood cultures was positive. 
Gram-negative bacilli were isolated 
(strain 3302398). Antimicrobial sus-
ceptibility testing showed decreased 
susceptibility to vancomycin, cefo-
tetan, and penicillin G. The strain pro-
duced β-lactamase as determined by 
Ceﬁ  nase test (Becton Dickinson, Le 
Pont de Claix, France).
The second patient was a 64-year-
old man with colon cancer who was 
receiving palliative chemotherapy 